Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Diabetes & Metabolism
|
January 3, 2012
Is continuous glucose monitoring (CGM) for everyone? To whom should CGM be prescribed and how?
J-P Riveline
Diabetes & Metabolism
|
March 22, 2007
How should postprandial glycemia be treated?
G Charpentier, D Dardari, J P Riveline
Diabetes & Metabolism
|
August 3, 2000
Management of drugs affecting blood glucose in diabetic patients with renal failure
G Charpentier, J P Riveline, M Varroud-Vial
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
January 26, 2005
[Optimising the equilibrium of diabetes and atheromatous progression: myth or reality?]
G Charpentier, J P Riveline, M L Virally
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
June 22, 2024
Perspective of Continuous Glucose Monitoring-Based Interventions at the Various Stages of Type 2 Diabetes
R A Ajjan, S Seidu, J P Riveline
Diabetes & Metabolism
|
November 9, 2007
Real-time continuous glucose monitoring using GuardianRT: from research to clinical practice
N Tubiana-Rufi, J-P Riveline, D Dardari
Diabetes & Metabolism
|
September 26, 2016
Glucagon-secretion inhibition using somatostatin: An old hormone for the treatment of diabetes-associated pancreatectomy
J-P Riveline, P Boudou, B Blondeau, et al.
Diabetes & Metabolism
|
December 3, 2014
Incretin-based therapy and pancreatic beta cells
S Chon, J-P Riveline, B Blondeau, et al.
Diabetes & Metabolism
|
August 12, 2003
Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications
J P Riveline, N Danchin, F Ledru, et al.
Diabetes & Metabolism
|
March 11, 2015
Metabolic roles of PGC-1α and its implications for type 2 diabetes
A Besseiche, J-P Riveline, J-F Gautier, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Diabetes & Metabolism
|
January 3, 2012
Is continuous glucose monitoring (CGM) for everyone? To whom should CGM be prescribed and how?
J-P Riveline
Diabetes & Metabolism
|
March 22, 2007
How should postprandial glycemia be treated?
G Charpentier, D Dardari, J P Riveline
Diabetes & Metabolism
|
August 3, 2000
Management of drugs affecting blood glucose in diabetic patients with renal failure
G Charpentier, J P Riveline, M Varroud-Vial
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
January 26, 2005
[Optimising the equilibrium of diabetes and atheromatous progression: myth or reality?]
G Charpentier, J P Riveline, M L Virally
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
June 22, 2024
Perspective of Continuous Glucose Monitoring-Based Interventions at the Various Stages of Type 2 Diabetes
R A Ajjan, S Seidu, J P Riveline
Diabetes & Metabolism
|
November 9, 2007
Real-time continuous glucose monitoring using GuardianRT: from research to clinical practice
N Tubiana-Rufi, J-P Riveline, D Dardari
Diabetes & Metabolism
|
September 26, 2016
Glucagon-secretion inhibition using somatostatin: An old hormone for the treatment of diabetes-associated pancreatectomy
J-P Riveline, P Boudou, B Blondeau, et al.
Diabetes & Metabolism
|
December 3, 2014
Incretin-based therapy and pancreatic beta cells
S Chon, J-P Riveline, B Blondeau, et al.
Diabetes & Metabolism
|
August 12, 2003
Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications
J P Riveline, N Danchin, F Ledru, et al.
Diabetes & Metabolism
|
March 11, 2015
Metabolic roles of PGC-1α and its implications for type 2 diabetes
A Besseiche, J-P Riveline, J-F Gautier, et al.
Page
of 4